Abedi S, Doosti A, Jami M-S (2020) Impacts of the prostate stem cell antigen (PSCA) and Clostridium perfringens enterotoxin (CPE) on the apoptosis and cell cycle regulatory genes in PC3. Prep Biochem Biotechnol 50(1):47–55
Article CAS PubMed Google Scholar
Ahmed S, Alam W, Jeandet P, Aschner M, Alsharif KF, Saso L, Khan H (2022) Therapeutic potential of marine peptides in prostate cancer: mechanistic insights. Mar Drugs 20(8):466
Article CAS PubMed PubMed Central Google Scholar
Baindara P, Gautam A, Raghava G, Korpole S (2017) Anticancer properties of a defensin like class IId bacteriocin Laterosporulin10. Sci Rep 7:46541
Article CAS PubMed PubMed Central Google Scholar
Bandala C, Cortés-Algara A, Mejía-Barradas C, Ilizaliturri-Flores I, Dominguez-Rubio R, Bazán-Méndez C, Floriano-Sánchez E, Luna-Arias J, Anaya-Ruiz M, Lara-Padilla E (2015) Botulinum neurotoxin type a inhibits synaptic vesicle 2 expression in breast cancer cell lines. Int J Clin Exp Pathol 8(7):8411
CAS PubMed PubMed Central Google Scholar
Barnes BB, Steindorf K, Hein R, Flesch-Janys D, Chang-Claude J (2011) Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors. Cancer Epidemiol 35(4):345–352
Baudelet C, Cron GO, Dessy C, Martinive P, De Wever J, Verrax J, Beghein N, Gr V, Calderon PB, Feron O (2006) Botulinum toxin potentiates cancer radiotherapy and chemotherapy. Clin Cancer Res 12(4):1276–1283
Black JD, Lopez S, Cocco E, Schwab CL, English DP, Santin AD (2015) Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancers. Toxins 7(4):1116–1125
Article CAS PubMed PubMed Central Google Scholar
Bocchetta M, Eliasz S, De Marco MA, Rudzinski J, Zhang L, Carbone M (2008) The SV40 large T antigen-p53 complexes bind and activate the insulin-like growth factor-I promoter stimulating cell growth. Cancer Res 68(4):1022–1029
Article CAS PubMed Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 68(6):394–424
C.Eckert AE, Monnier ALe, Cathala L, Montclos HDe, Goret J, Berger P, Petit A, Chevigny ADe, Pierre HJean, Nebbad B, Camiade S, Meckenstock R, .Lalande V, Marchandin H, F.Barbut (2015) Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins a and B. New Microbes New Infect 3:12–17
Cao C, Yan TD, Black D, Morris DL (2009) A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 16(8):2152–2165
Caputi V, Giron MC (2018) Microbiome-gut-brain axis and toll-like receptors in Parkinson’s disease. Int J Mol Sci 19(6):1689
Article PubMed PubMed Central Google Scholar
Chang J, Liu Y, Han B, Zhou C, Bai C, Li J (2015) Pseudomonas aeruginosa preparation plus chemotherapy for advanced non-small-cell lung cancer: a randomized, multicenter, double-blind phase III study. Med Oncol 32(5):139
Chaturvedi R, Asim M, Romero–Gallo J, Barry DP, Hoge S, De Sablet T, Delgado AG, Wroblewski LE, Piazuelo MB, Yan F (2011) Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterol 141(5):1696–1708
Chen J, Vitetta L (2018) Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin Colorectal Cancer 17(3):e541–e544
Chen J, Xu X-M, Underhill CB, Yang S, Wang L, Chen Y, Hong S, Creswell K, Zhang L (2005) Tachyplesin activates the classic complement pathway to kill tumor cells. Cancer Res 65(11):4614–4622
Article CAS PubMed Google Scholar
Choi S-W, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132(8):2413S–2418S
Article CAS PubMed Google Scholar
Cirne F, Kappel C, Zhou S, Mukherjee SD, Dehghan M, Petropoulos J-A, Leong DP (2022) Modifiable risk factors for prostate cancer in low-and lower-middle-income countries: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 25(3):453–462
Clairmont C, Lee K, Pike J, Ittensohn M, Low K, Pawelek J, Bermudes D, Brecher S, Margitich D, Turnier J (2000) Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimuvium. J Infect Dis 181(6):1996–2002
Article CAS PubMed Google Scholar
Coelho A, Dinis P, Pinto R, Gorgal T, Silva C, Silva A, Silva J, Cruz CD, Cruz F, Avelino A (2010) Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder. Eur Urol 57(5):884–890
Article CAS PubMed Google Scholar
Danino T, Prindle A, Hasty J, Bhatia S (2013) Measuring growth and gene expression dynamics of tumor-targeted S. typhimurium bacteria. J Vis Exp 77:50540
de Groot M, Toering ST, Boer K, Spliet WG, Heimans JJ, Aronica E, Reijneveld JC (2010) Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex. Neurooncology 12(3):265–273
De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155(6):1985–1992
Article PubMed PubMed Central Google Scholar
De Marzo AM, DeWeese TL, Platz EA, Meeker AK, Nakayama M, Epstein JI, Isaacs WB, Nelson WG (2004) Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 91(3):459–477
Debelec-Butuner B, Alapinar C, Varisli L, Erbaykent‐Tepedelen B, Hamid SM, Gonen‐Korkmaz C, Korkmaz KS (2014) Inflammation‐mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation. Mol Carcinog 53(2):85–97
Article CAS PubMed Google Scholar
Dembiński A, Warzecha Z, Ceranowicz P, Dembiński M, Cieszkowski J, Gosiewski T, Bulanda M, Kuśnierz-Cabala B, Gałązka K, Konturek PC (2016) Synergic interaction of rifaximin and mutaflor (Escherichia coli Nissle 1917) in the treatment of acetic acid-induced colitis in rats. Gastroenterol Res Pract. https://doi.org/10.1155/2016/3126280
Article PubMed PubMed Central Google Scholar
Denny WA (2004) Tumor-activated prodrugs—a new approach to cancer therapy. Cancer Invest 22(4):604–619
Article CAS PubMed Google Scholar
DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. Cancer J Clin 64(4):252–271
Ding L, Lu Z, Lu Q, Chen Y-H (2013) The claudin family of proteins in human malignancy: a clinical perspective. Cancer Manag Res 5:367
PubMed PubMed Central Google Scholar
Dodd JG, Paraskevas M, Mcnicol PJ (1993) Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 149(2):400–402
Article CAS PubMed Google Scholar
Dong M, Yeh F, Tepp WH, Dean C, Johnson EA, Janz R, Chapman ER (2006) SV2 is the protein receptor for botulinum neurotoxin A. Science 312(5773):592–596
Article CAS PubMed Google Scholar
Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W (2007) Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 67(1):14–21
Fatemipour M, Nahand JS, Azar MEF, Baghi HB, Taghizadieh M, Sorayyayi S, Hussen BM, Mirzaei H, Moghoofei M, Bokharaei-Salim F (2021) Human papillomavirus and prostate cancer: the role of viral expressed proteins in the inhibition of anoikis and induction of metastasis. Microb Pathog 152:104576
Article CAS PubMed Google Scholar
Fayette J, Soria J-C, Armand J-P (2005) Use of angiogenesis inhibitors in tumour treatment. Eur J Cancer 41(8):1109–1116
Article CAS PubMed Google Scholar
Fehri LF, Mak TN, Laube B, Brinkmann V, Ogilvie LA, Mollenkopf H, Lein M, Schmidt T, Meyer TF, Brüggemann H (2011) Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells. Int J Med Microbiol 301(1):69–78
Fiedler T, Strauss M, Hering S, Redanz U, William D, Rosche Y, Classen CF, Kreikemeyer B, Linnebacher M, Maletzki C (2015) Arginine deprivation by arginine deiminase of Streptococcus pyogenes controls primary glioblastoma growth in vitro and in vivo. Cancer Biol Ther 16(7):1047–1055
Article CAS PubMed PubMed Central Google Scholar
Fujimori M (2006) Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 13(1):27–31
Ganai S, Arenas RB, Sauer JP, Bentley B, Forbes NS (2011) In tumors Salmonella migrate away from vasculature toward the transition zone and induce apoptosis. Cancer Gene Ther 18(7):457
Comments (0)